Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of 17.62% is 64% above its 5-year average of 10.76%, around the middle of its 5-year range (-5.15%–35.77%).
13.60% above its 12-month average of 15.51%.
Reported quarterly profit margin; no daily interpolation. Q4 FY2026 (2026-06-30): 14.00%.
NET PROFIT MARGIN
17.62%
NET PROFIT MARGIN AVG TTM
15.51%
NET PROFIT MARGIN AVG 3Y
13.45%
NET PROFIT MARGIN AVG 5Y
10.76%
NET PROFIT MARGIN AVG 10Y
11.82%
NET PROFIT MARGIN AVG 15Y
7.00%
NET PROFIT MARGIN AVG 20Y
6.42%
CURRENT VS TTM AVG
+13.60%
CURRENT VS 3Y AVG
+31.04%
CURRENT VS 5Y AVG
+63.74%
CURRENT VS 10Y AVG
+49.13%
CURRENT VS 15Y AVG
+151.71%
CURRENT VS 20Y AVG
+174.47%
SECTOR MEDIAN · HEALTHCARE
-0.26%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
+6876.92%
vs the sector median at left
Pro-Dex, Inc.
Market Cap
$207.59M
Net Profit Margin
17.62%
TTM Avg
15.51%
3Y Avg
13.45%
5Y Avg
10.76%
Market Cap
$207.51M
Net Profit Margin
-288.26%
TTM Avg
-266.69%
3Y Avg
-300.28%
5Y Avg
-1842.40%
Market Cap
$208.94M
Net Profit Margin
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$209.19M
Net Profit Margin
-3537.73%
TTM Avg
-267.18%
3Y Avg
-134.88%
5Y Avg
-89.92%
Market Cap
$205.43M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$204.05M
Net Profit Margin
-10422.48%
TTM Avg
-2428.80%
3Y Avg
-1417.64%
5Y Avg
-1019.29%
Market Cap
$211.71M
Net Profit Margin
47.55%
TTM Avg
-1.25%
3Y Avg
-126.95%
5Y Avg
-427.13%
Market Cap
$202.62M
Net Profit Margin
-850.13%
TTM Avg
-398.77%
3Y Avg
-257.91%
5Y Avg
-325.14%
Market Cap
$202.58M
Net Profit Margin
-26.61%
TTM Avg
-28.57%
3Y Avg
-51.55%
5Y Avg
-50.26%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Pro-Dex, Inc. (PDEX) | $207.59M | 17.62% | 15.51% | 13.45% | 10.76% |
| Whitehawk Therapeutics Inc (WHWK)vs › | $207.51M | -288.26% | -266.69% | -300.28% | -1842.40% |
| Electra Therapeutics Inc. (ETRA)vs › | $208.94M | N/A | N/A | N/A | N/A |
| Entrada Therapeutics, Inc. (TRDA)vs › | $209.19M | -3537.73% | -267.18% | -134.88% | -89.92% |
| Sionna Therapeutics, Inc. (SION)vs › | $205.43M | 0.00% | 0.00% | 0.00% | 0.00% |
| Cartesian Therapeutics, Inc. (RNAC)vs › | $204.05M | -10422.48% | -2428.80% | -1417.64% | -1019.29% |
| Compugen Ltd. (CGEN)vs › | $211.71M | 47.55% | -1.25% | -126.95% | -427.13% |
| Alector, Inc. (ALEC)vs › | $202.62M | -850.13% | -398.77% | -257.91% | -325.14% |
| Exagen Inc. (XGN)vs › | $202.58M | -26.61% | -28.57% | -51.55% | -50.26% |
| Prelude Therapeutics Incorporated (PRLD)vs › | $212.75M | -269.75% | -1318.17% | -659.09% | -439.39% |
Operating Margin
16.8%
Net Profit Margin
17.6%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 14.00% |
| 2026-03-31 | 19.74% |
| 2025-12-31 | 11.72% |
| 2025-09-30 | 25.26% |
| 2025-06-30 | 6.84% |
| 2025-03-31 | 18.81% |
| 2024-12-31 | 12.15% |
| 2024-09-30 | 16.56% |
| 2024-06-30 | 10.56% |
| 2024-03-31 | 4.58% |
| 2023-12-31 | 3.97% |
| 2023-09-30 | -5.15% |
| 2023-06-30 | 35.77% |
| 2023-03-31 | 12.36% |
| 2022-12-31 | 7.79% |
| 2022-09-30 | 9.71% |
| 2022-06-30 | 11.14% |
| 2022-03-31 | 4.99% |
| 2021-12-31 | 9.09% |
| 2021-09-30 | 10.65% |
| 2021-06-30 | 9.04% |
| 2021-03-31 | 16.99% |
| 2020-12-31 | 4.08% |
| 2020-09-30 | 14.73% |
| 2020-06-30 | 22.89% |
| 2020-03-31 | 14.26% |
| 2019-12-31 | 15.69% |
| 2019-09-30 | 15.25% |
| 2019-06-30 | 12.68% |
| 2019-03-31 | 10.68% |
| 2018-12-31 | 18.42% |
| 2018-09-30 | 19.51% |
| 2018-06-30 | 2.69% |
| 2018-03-31 | 8.74% |
| 2017-12-31 | 6.21% |
| 2017-09-30 | 12.17% |
| 2017-06-30 | 12.79% |
| 2017-03-31 | 13.42% |
| 2016-12-31 | 69.45% |
| 2016-09-30 | 5.28% |
| 2016-06-30 | 3.58% |
| 2016-03-31 | 6.90% |
| 2015-12-31 | 7.19% |
| 2015-09-30 | -3.05% |
| 2015-06-30 | 1.79% |
| 2015-03-31 | -1.94% |
| 2014-12-31 | -6.88% |
| 2014-09-30 | -6.55% |
| 2014-06-30 | 0.75% |
| 2014-03-31 | -16.01% |
| 2013-12-31 | -12.80% |
| 2013-09-30 | 8.30% |
| 2013-06-30 | -24.69% |
| 2013-03-31 | -24.41% |
| 2012-12-31 | -11.57% |
| 2012-09-30 | -0.49% |
| 2012-06-30 | -14.88% |
| 2012-03-31 | -10.73% |
| 2011-12-31 | -5.95% |
| 2011-09-30 | 7.40% |
| 2011-06-30 | 13.71% |
| 2011-03-31 | 11.38% |
| 2010-12-31 | 6.51% |
| 2010-09-30 | 5.87% |
| 2010-06-30 | -68.26% |
| 2010-03-31 | 2.82% |
| 2009-12-31 | 10.18% |
| 2009-09-30 | 3.25% |
| 2009-06-30 | 3.59% |
| 2009-03-31 | -65.34% |
| 2008-12-31 | 1.55% |
| 2008-09-30 | -2.09% |
| 2008-06-30 | -7.63% |
| 2008-03-31 | 1.30% |
| 2007-12-31 | 4.98% |
| 2007-09-30 | 5.44% |
| 2007-06-30 | 3.23% |
| 2007-03-31 | 3.65% |
| 2006-12-31 | -2.98% |
| 2006-09-30 | 4.62% |
| 2006-06-30 | 4.33% |
| 2006-03-31 | 0.14% |
| 2005-12-31 | 8.72% |
| 2005-09-30 | 6.96% |
| 2005-06-30 | 21.25% |
| 2005-03-31 | 8.49% |
| 2004-12-31 | 6.32% |
| 2004-09-30 | 13.87% |
| 2004-06-30 | 11.92% |
| 2004-03-31 | 7.90% |
| 2003-12-31 | 6.21% |
| 2003-09-30 | 5.47% |
| 2003-06-30 | 3.38% |
| 2003-03-31 | 1.82% |
| 2002-12-31 | -1.01% |
| 2002-09-30 | -0.22% |
